Section 11165.4 of the Health and Safety Code, sets forth the requirements for mandatory consultation of CURES. Prescribers and Pharmacists can register by accessing the CURES User Registration.
PMP AWARE LOGIN REGISTRATION
Prescriber and Pharmacist registration to access CURES is simple and fully automated. California licensed pharmacists must register for access to CURES upon issuance of a Board of Pharmacy Pharmacist License.
PMP AWARE LOGIN CODE
CURES Registration RequirementsĬalifornia law (Health and Safety Code Section 11165.1) requires all California licensed health care practitioners authorized to prescribe Schedule II, Schedule III, Schedule IV and Schedule V controlled substances to register for access to CURES upon issuance of a Drug Enforcement Administration Controlled Substance Registration Certificate. Regulatory agency officials and law enforcement officials may access information in CURES only to assist the efforts of their agencies to control the diversion and resultant abuse of controlled substances. Licensed health care practitioners and licensed pharmacists may access information in CURES only for patients under their care. The controlled substances dispensation history of an individual that is received by a practitioner or pharmacist from CURES is subject to the Confidentiality of Medical Information Act and the Health Insurance Portability and Accountability Act of 1996 (HIPAA), including the HIPAA regulations in 45 Code of Federal Regulations parts 160 and 164.Īccess to CURES is strictly limited. The operation of CURES complies with all applicable federal and state privacy and security laws and regulations. CURES is committed to the reduction of prescription drug abuse and diversion without affecting legitimate medical practice or patient care. Controlled Substance Utilization Review and Evaluation System California’s Prescription Drug Monitoring ProgramĬURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement. The second sample Delegate Agreement demonstrates an agreement between one Authorizing User and multiple Delegates.ĭetailed information concerning Delegate eligibility and Delegate Agreement requirements are described in DOJ’s October 14, 2022, bulletin entitled, New Features and Requirements for Expanded Delegate Access. The first sample Delegate Agreement demonstrates an agreement between one Authorizing User and one Delegate.
For detailed information view the Quick Reference Guide.ĭOJ has also created two sample Delegate Agreements.
PMP AWARE LOGIN HOW TO
The Department of Justice (DOJ) has created a Quick Reference Guide that details how to establish and activate a Delegate in the optimized CURES, along with questions and answers. To continue using Delegates after April 11, 2022, new Delegate associations must be established. The optimized CURES includes expanded Delegate functionality, which allows Delegates to directly access data in CURES.Īll prior Delegate associations were disabled upon the release of the optimized CURES on April 11, 2022. New Requirements for Expanded Delegate Functionality
0 kommentar(er)
